Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospectsHongyi Li, Xia Zhao|Signal Transduction and Targeted Therapy|2020Cited by 1.7k
Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancerYing Xiong, Xia Zhao, Kehui Xu et al.|Bioscience Reports|2020Cited by 17
LBA1 | THE BENEFIT OF POLA‐R‐CHP IN DLBclass‐DEFINED MOLECULAR SUBSETS OF NEWLY DIAGNOSED DLBCL IN THE POLARIX TRIALEleonora Calabretta, Margaret A. Shipp, Kun Ping Lu et al.|Hematological Oncology|2025Cited by 9